These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Psychostimulants for secondary depression in medical illness. Masand P; Pickett P; Murray GB Psychosomatics; 1991; 32(2):203-8. PubMed ID: 2027944 [TBL] [Abstract][Full Text] [Related]
3. Psychostimulants for depression in hospitalized cancer patients. Olin J; Masand P Psychosomatics; 1996; 37(1):57-62. PubMed ID: 8600496 [TBL] [Abstract][Full Text] [Related]
4. Psychostimulant treatment of geriatric depressive disorders secondary to medical illness. Pickett P; Masand P; Murray GB J Geriatr Psychiatry Neurol; 1990; 3(3):146-51. PubMed ID: 2282130 [TBL] [Abstract][Full Text] [Related]
5. Do the old psychostimulant drugs have a role in managing treatment-resistant depression? Parker G; Brotchie H Acta Psychiatr Scand; 2010 Apr; 121(4):308-14. PubMed ID: 19594481 [TBL] [Abstract][Full Text] [Related]
8. Medical use of psychostimulants: an overview. Holmes VF Int J Psychiatry Med; 1995; 25(1):1-19. PubMed ID: 7649714 [No Abstract] [Full Text] [Related]
9. Psychostimulants for managing unipolar and bipolar treatment-resistant melancholic depression: a medium-term evaluation of cost benefits. Parker G; Brotchie H; McClure G; Fletcher K J Affect Disord; 2013 Oct; 151(1):360-4. PubMed ID: 23810360 [TBL] [Abstract][Full Text] [Related]
10. Stimulants for depression: On the up and up? Malhi GS; Byrow Y; Bassett D; Boyce P; Hopwood M; Lyndon W; Mulder R; Porter R; Singh A; Murray G Aust N Z J Psychiatry; 2016 Mar; 50(3):203-7. PubMed ID: 26906078 [TBL] [Abstract][Full Text] [Related]
11. Psychostimulants in supportive care. Homsi J; Walsh D; Nelson KA Support Care Cancer; 2000 Sep; 8(5):385-97. PubMed ID: 10975688 [TBL] [Abstract][Full Text] [Related]
15. Stimulants in the treatment of depression: a critical overview. Satel SL; Nelson JC J Clin Psychiatry; 1989 Jul; 50(7):241-9. PubMed ID: 2567730 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and side effects of methylphenidate for poststroke depression. Lazarus LW; Winemiller DR; Lingam VR; Neyman I; Hartman C; Abassian M; Kartan U; Groves L; Fawcett J J Clin Psychiatry; 1992 Dec; 53(12):447-9. PubMed ID: 1487474 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of risks associated with short- and long-term psychostimulant therapy for treatment of ADHD in children. Kociancic T; Reed MD; Findling RL Expert Opin Drug Saf; 2004 Mar; 3(2):93-100. PubMed ID: 15006715 [TBL] [Abstract][Full Text] [Related]
18. Methylphenidate in stroke patients with depression. Johnson ML; Roberts MD; Ross AR; Witten CM Am J Phys Med Rehabil; 1992 Aug; 71(4):239-41. PubMed ID: 1642825 [TBL] [Abstract][Full Text] [Related]
19. Methylphenidate in post liver transplant patients. Plutchik L; Snyder S; Drooker M; Chodoff L; Sheiner P Psychosomatics; 1998; 39(2):118-23. PubMed ID: 9584537 [TBL] [Abstract][Full Text] [Related]
20. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient. Kollins SH J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]